NASDAQ$BTTC

Black Titan Corp · Q1 2014 earnings

Q1 2014 earnings · · Investor relations

Headline financials

Total Revenue

$911K

Previous: $5.17M-82.4%
EPS (adj)

-$0.60

Previous: $2.40-125.0%
Capital Expenditures

$2K

Previous: $180K-98.9%
Net Income

-$1.8M

Previous: $6M-130.1%
Operating Income

-$934K

Previous: $171K-646.2%
Gross Profit

-$38K

Previous: $1.26M-103.0%
Cash & Equivalents

$10.2M

Previous: $17.6M-41.8%
Total Assets

$16.1M

Previous: $23.5M-31.5%
Stock-Based Comp

$326K

Previous: $505K-35.4%

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$911K

Q1 2014-82.4%vs Q1 2013
Beat estimate in 4 of 4 quarters(100%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro